ArticleLeukemia2021

Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia.

Zheng Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.